Congress
HemaSphere
About EHA
Search
Connect & Network
Clinical practice
Education & Training
Research & Innovation
Join EHA
Login
EHA2025 Congress
EHA2026 Congress
Meetings
Membership and benefits
Congress platform
EHA Perspectives Congress Reports
EHA2025 program
EHA2025 details and deadlines
Sponsorship opportunities
EHA2025 gallery
Sustainability
Full membership
Junior membership
Trial membership
Healthcare-affiliated professional membership
Emeritus membership
Joint EHA and national society membership
Using MyEHA
Wednesday, July 2, 2025
EHA Perspectives Congress Reports
Our guidelines initiative
Guidelines by areas of disease
Guidelines endorsed by EHA
EHA Guidelines app
Guidelines for high dose chemotherapy and stem cell transplantation for systemic AL amyloidosis: EHA-ISA working group guidelines
Guidelines for non-transplant chemotherapy for treatment of systemic AL amyloidosis: EHA-ISA working group
Recommendations regarding splenectomy in hereditary hemolytic anemias
Recommendations for Pregnancy in Rare Inherited Anemias
The Use of Next-generation Sequencing in the Diagnosis of Rare Inherited Anaemias: A Joint BSH/EHA Good Practice Paper
EHA Guidelines on Management of Antithrombotic Treatments in Thrombocytopenic Patients With Cancer
Antithrombotic Treatment in Patients With Hemophilia: an EHA-ISTH-EAHAD-ESO Clinical Practice Guidance
Fundamentals for a Systematic Approach to Mild and Moderate Inherited Bleeding Disorders: An EHA Consensus Report
ESC Guidelines on cardio-oncology
Diagnosis and Treatment of Chronic Myelomonocytic Leukemias in Adults
Antifungal prophylaxis in adult patients with acute myeloid leukemia treated with novel targeted therapies
Human immunodeficiency virus-associated Lymphomas: EHA–ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up
Primary central nervous system lymphomas: EHA–ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up
Guidelines for the Use and Reporting of Patient-Reported Outcomes in Multiple Myeloma Clinical Trials
Multiple Myeloma: EHA-ESMO Clinical Practice Guidelines for Diagnosis, Treatment and Follow-up
Recommendations for diagnosis and treatment of methemoglobinemia
The European Guidelines on Diagnosis and Management of Neutropenia in Adults and Children
Management of Pregnancy in Rare Inherited Anemias
European guidelines on treatment and supportive measures in chronic neutropenias
Peripheral T- and natural killer-cell lymphomas: ESMO-EHA Clinical Practice Guideline for diagnosis, treatment, and follow-up
EHA-EMN Evidence-Based Guidelines for diagnosis, treatment and follow-up of patients with multiple myeloma
Wednesday, July 2, 2025
EHA Perspectives Congress Reports
EHA Campus
Learning paths
Tests and tools
Mentoring and career development
European Hematology Curriculum
Lighting the Flame program
EHA Diagnosis
EHA Exam
Progress Test
Career comparison tool
EHA Mentorship Program
Master Class
Research training programs
Wednesday, July 2, 2025
EHA Perspectives Congress Reports
HemaSphere
Specialized Working Groups
Grants
Topics-in-Focus program
Support for SWG scientific meetings
SWG Grants
How to apply to join an SWG
Webinars and online groups
EHA Research Grants
EHA Bilateral Collaborative Grant
EHA Innovation Grant
EHA Kick-off Grant
EHA Research Mobility Grant
EHA Travel Grants
EHA Grants Hall of Fame
Non-EHA funding opportunities
Scope of our grants
Precision Hematology Topics-in-Focus program
Hemoglobinopathies Topics-in-Focus program
Wednesday, July 2, 2025
EHA Perspectives Congress Reports
Menu
Close
Connect & Network
EHA2025 Congress
Congress platform
EHA Perspectives Congress Reports
EHA2025 program
EHA2025 details and deadlines
Sponsorship opportunities
EHA2025 gallery
Sustainability
EHA2026 Congress
Meetings
Membership and benefits
Full membership
Junior membership
Trial membership
Healthcare-affiliated professional membership
Emeritus membership
Joint EHA and national society membership
Using MyEHA
Clinical practice
Our guidelines initiative
Guidelines by areas of disease
Guidelines for high dose chemotherapy and stem cell transplantation for systemic AL amyloidosis: EHA-ISA working group guidelines
Guidelines for non-transplant chemotherapy for treatment of systemic AL amyloidosis: EHA-ISA working group
Recommendations regarding splenectomy in hereditary hemolytic anemias
Recommendations for Pregnancy in Rare Inherited Anemias
The Use of Next-generation Sequencing in the Diagnosis of Rare Inherited Anaemias: A Joint BSH/EHA Good Practice Paper
EHA Guidelines on Management of Antithrombotic Treatments in Thrombocytopenic Patients With Cancer
Antithrombotic Treatment in Patients With Hemophilia: an EHA-ISTH-EAHAD-ESO Clinical Practice Guidance
Fundamentals for a Systematic Approach to Mild and Moderate Inherited Bleeding Disorders: An EHA Consensus Report
ESC Guidelines on cardio-oncology
Diagnosis and Treatment of Chronic Myelomonocytic Leukemias in Adults
Antifungal prophylaxis in adult patients with acute myeloid leukemia treated with novel targeted therapies
Human immunodeficiency virus-associated Lymphomas: EHA–ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up
Primary central nervous system lymphomas: EHA–ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up
Guidelines for the Use and Reporting of Patient-Reported Outcomes in Multiple Myeloma Clinical Trials
Multiple Myeloma: EHA-ESMO Clinical Practice Guidelines for Diagnosis, Treatment and Follow-up
Recommendations for diagnosis and treatment of methemoglobinemia
The European Guidelines on Diagnosis and Management of Neutropenia in Adults and Children
Management of Pregnancy in Rare Inherited Anemias
European guidelines on treatment and supportive measures in chronic neutropenias
Peripheral T- and natural killer-cell lymphomas: ESMO-EHA Clinical Practice Guideline for diagnosis, treatment, and follow-up
EHA-EMN Evidence-Based Guidelines for diagnosis, treatment and follow-up of patients with multiple myeloma
Guidelines endorsed by EHA
EHA Guidelines app
Education & Training
EHA Campus
Learning paths
European Hematology Curriculum
Lighting the Flame program
Tests and tools
EHA Diagnosis
EHA Exam
Progress Test
Mentoring and career development
Career comparison tool
EHA Mentorship Program
Master Class
Research training programs
Research & Innovation
HemaSphere
Specialized Working Groups
Support for SWG scientific meetings
SWG Grants
How to apply to join an SWG
Webinars and online groups
Grants
EHA Research Grants
EHA Bilateral Collaborative Grant
EHA Innovation Grant
EHA Kick-off Grant
EHA Research Mobility Grant
EHA Travel Grants
EHA Grants Hall of Fame
Non-EHA funding opportunities
Scope of our grants
Topics-in-Focus program
Precision Hematology Topics-in-Focus program
Hemoglobinopathies Topics-in-Focus program
Congress
HemaSphere
About EHA
Search
Join EHA
Login
Home
About EHA
European affairs
Regulatory affairs and scientific relations
Selected EMA news
Selected EMA news, August 2025
Selected EMA news, August 2025
New information on approved medicines
Alhemo
(
concizumab
) – extension of indication
Treatment of haemophilia A and B
Withdrawal of applications for new medicines
Aplidin
(
plitidepsin
)
Intended for the treatment of multiple myeloma (cancer of the bone marrow)
Share
Selected EMA news
Selected EMA news archive
Selected EMA news, June 2025
Selected EMA news, July 2025
Selected EMA news, August 2025
Read the EHA Perspectives Congress Reports
EHA Perspectives Congress Reports
Deep dives into the state of hematology
Read the reports now